Stage II-IIIB Non-small Cell Lung Carcinoma
Oncology
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| osimertinib 80 mg/40 mg | ASTRAZENECA PLC (AZN) |
Frequently asked questions
How many drugs are in development for Stage II-IIIB Non-small Cell Lung Carcinoma?
BioSniper tracks 1 drug in development for Stage II-IIIB Non-small Cell Lung Carcinoma across 1 company.
How many clinical trials target Stage II-IIIB Non-small Cell Lung Carcinoma?
There are 1 clinical trial targeting Stage II-IIIB Non-small Cell Lung Carcinoma tracked by BioSniper.
Deep-dive into Stage II-IIIB Non-small Cell Lung Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis